Europe Archives - Page 65 of 93 - Journal for Clinical Studies

Current Edition

Europe

7th Annual Publication and Clinical Trial Transparency

Date: June 20-21, 2018 Location: Amsterdam, The Netherlands In its 7th year, CBI’s Publication and Clinical Trial Transparency creates a bridge between the key stak...

6 June 2018 Europe 7th | annual

Continue Reading →

Europe

Speeding Drug Development with Clinical Trials in a Dish

The average time to bring a new drug to market is 12 years—assuming it makes it through the rigorous regulatory hurdles. Any technology or methodology that can exped...

6 June 2018 Europe clinical | development

Continue Reading →

Europe

NCI-MATCH precision medicine clinical trial releases new findings

The National Cancer Institute's Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has achieved a milestone wi...

6 June 2018 Europe ASCO | clinical

Continue Reading →

Europe

New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma

Patients treated with cemiplimab experienced robust anti-tumor effects Data also presented today at the 2018 ASCO Annual Meeting Cemiplimab applications unde...

6 June 2018 Europe | North America anti-PD-1 | anti-tumour

Continue Reading →

Europe

Phase II Clinical Trials of DCVAC Show Significant Benefit for Patients with Ovarian and Lung Cancer

SOTIO, a biotechnology company owned by the PPF Group, presented results from its Phase II clinical trials evaluating DCVAC, an active cellular immunotherapy product,...

6 June 2018 Europe clinical | DCVAC

Continue Reading →

Europe

ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma

Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and promising trends in overal...

6 June 2018 Europe 2018 | ASCO

Continue Reading →

Europe

Novo’s oral semaglutide outperforms Jardiance in late-stage study

Danish drugmaker Novo Nordisk said Tuesday its PIONEER 2 study testing oral semaglutide in patients with type 2 diabetes met its primary objective, showing a stat...

6 June 2018 Europe jardiance | late-stage

Continue Reading →

Europe

AstraZeneca won’t submit lung drug for COPD after 2nd study miss

AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the second of two Phase...

6 June 2018 Europe 2nd | AstraZeneca

Continue Reading →

Europe

Madrigal scores in mid-stage NASH study

Madrigal Pharmaceuticals on Thursday reported highly anticipated results for its Phase 2 non-alcoholic steatohepatitis (NASH) drug MGL-3196, unveiling positive da...

6 June 2018 Europe madrigal | mid-stage

Continue Reading →

Europe

In this era of personalised medicine, are big clinical trials relevant?

The debate is surging days before the results of a large clinical trial are to be unveiled this week Sweeping clinical trials in which thousands of patients are stud...

31 May 2018 Europe big | clinical

Continue Reading →